<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The link between <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and the complications of <z:mp ids='MP_0002055'>diabetes</z:mp> is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>It is still discussed whether <z:mp ids='MP_0003674'>oxidative stress</z:mp> precedes or merely reflects <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To search for a <z:hpo ids='HP_0001472'>familial predisposition</z:hpo> to <z:mp ids='MP_0003674'>oxidative stress</z:mp>, we investigated indexes of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism, markers of plasma and cell <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation, a marker of oxidant-induced protein damage, and the effects of oxygen radicals on erythrocytes (or red blood cells [RBCs]) of patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and their relatives </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: We recruited 30 type 1 diabetic subjects (10 without <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e>, 10 with <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, and 10 with <z:hpo ids='HP_0000112'>nephropathy</z:hpo>), 36 nondiabetic siblings, 37 nondiabetic parents of type 1 diabetic subjects, and 3 control groups of healthy subjects without a family history of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Levels of blood <z:chebi fb="0" ids="16737">creatinine</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA(1c), cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) (Lp[a]), fibrinogen, malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), and advanced oxidation protein products were determined </plain></SENT>
<SENT sid="5" pm="."><plain>The RBC response to <z:mp ids='MP_0003674'>oxidative stress</z:mp> (3-h incubation at 37 degrees C with or without a radical generating system) was evaluated by measuring RBC <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), RBC-<z:chebi fb="14" ids="32506">MDA</z:chebi>, and <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Diabetic patients had higher levels of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (P &lt; 0.001), HbA(1c) (P &lt; 0.001), Lp(a) (P &lt; 0.01), and fibrinogen (P &lt; 0.05) than control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Siblings of diabetic patients had higher Lp(a) levels (P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Parents had higher levels of plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (P &lt; 0.05) and Lp(a) (P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>Plasma and RBC-<z:chebi fb="14" ids="32506">MDA</z:chebi> were significantly elevated in diabetic subjects and relatives compared with control subjects </plain></SENT>
<SENT sid="10" pm="."><plain>Basal RBC-GSH was lower in diabetic subjects (P &lt; 0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>In diabetic subjects, incubations of cells caused a decrease in RBC-GSH of a lesser degree than that in control subjects, but they caused a significant increase in <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Among relatives, <z:mp ids='MP_0010163'>hemolysis</z:mp> was increased both at baseline and after incubation </plain></SENT>
<SENT sid="13" pm="."><plain>Plasma <z:chebi fb="14" ids="32506">MDA</z:chebi> levels were associated with blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, and fibrinogen levels (multiple r = 0.5, P &lt; 0.001), and basal RBC-<z:chebi fb="14" ids="32506">MDA</z:chebi> levels were associated with plasma Lp(a), fibrinogen, and plasma <z:chebi fb="14" ids="32506">MDA</z:chebi> levels (r = 0.6, P &lt; 0.001) </plain></SENT>
<SENT sid="14" pm="."><plain>Basal RBC-GSH content correlated with serum <z:chebi fb="105" ids="17234">glucose</z:chebi> and RBC-<z:chebi fb="14" ids="32506">MDA</z:chebi> production (r = 0.3, P &lt; 0.01) </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: Our study is the first to present evidence that markers of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism (Lp[a]), <z:mp ids='MP_0003674'>oxidative stress</z:mp> (plasma and RBC-<z:chebi fb="14" ids="32506">MDA</z:chebi>), and cellular fragility (<z:mp ids='MP_0010163'>hemolysis</z:mp>) are abnormal in nondiabetic relatives of type 1 diabetic subjects, thereby supporting the view that familial elements of <z:mp ids='MP_0002055'>diabetes</z:mp> even precede the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="16" pm="."><plain>It seems reasonable that the same biological markers considered major predictors of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> can also trace familial susceptibility to type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, just as they have been associated with the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>